» Articles » PMID: 31106044

Integrated Analysis Reveals Five Potential CeRNA Biomarkers in Human Lung Adenocarcinoma

Overview
Journal PeerJ
Date 2019 May 21
PMID 31106044
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Competing endogenous RNAs (ceRNAs) are a newly identified type of regulatory RNA. Accumulating evidence suggests that ceRNAs play an important role in the pathogenesis of diseases such as cancer. Thus, ceRNA dysregulation may represent an important molecular mechanism underlying cancer progression and poor prognosis. In this study, we aimed to identify ceRNAs that may serve as potential biomarkers for early diagnosis of lung adenocarcinoma (LUAD).

Methods: We performed differential gene expression analysis on TCGA-LUAD datasets to identify differentially expressed (DE) mRNAs, lncRNAs, and miRNAs at different tumor stages. Based on the ceRNA hypothesis and considering the synergistic or feedback regulation of ceRNAs, a lncRNA-miRNA-mRNA network was constructed. Functional analysis was performed using gene ontology term and KEGG pathway enrichment analysis and KOBAS 2.0 software. Transcription factor (TF) analysis was carried out to identify direct targets of the TFs associated with LUAD prognosis. Identified DE genes were validated using gene expression omnibus (GEO) datasets.

Results: Based on analysis of TCGA-LUAD datasets, we obtained 2,610 DE mRNAs, 915 lncRNAs, and 125 miRNAs that were common to different tumor stages (|log(Fold change)| ≥ 1, false discovery rate < 0.01), respectively. Functional analysis showed that the aberrantly expressed mRNAs were closely related to tumor development. Survival analyses of the constructed ceRNA network modules demonstrated that five of them exhibit prognostic significance. The five ceRNA interaction modules contained one lncRNA (FENDRR), three mRNAs (EPAS1, FOXF1, and EDNRB), and four miRNAs (hsa-miR-148a, hsa-miR-195, hsa-miR-196b, and hsa-miR-301b). The aberrant expression of one lncRNA and three mRNAs was verified in the LUAD GEO dataset. Transcription factor analysis demonstrated that EPAS1 directly targeted 13 DE mRNAs.

Conclusion: Our observations indicate that lncRNA-related ceRNAs and TFs play an important role in LUAD. The present study provides novel insights into the molecular mechanisms underlying LUAD pathogenesis. Furthermore, our study facilitates the identification of potential biomarkers for the early diagnosis and prognosis of LUAD and therapeutic targets for its treatment.

Citing Articles

Hypoxia-associated prognostic markers and competing endogenous RNA coexpression networks in lung adenocarcinoma.

Xiong L, He X, Wang L, Dai P, Zhao J, Zhou X Sci Rep. 2022; 12(1):21340.

PMID: 36494419 PMC: 9734750. DOI: 10.1038/s41598-022-25745-7.


Genome-wide identification and functional analysis of circRNAs in Trichophyton rubrum conidial and mycelial stages.

Cao X, Xu X, Dong J, Xue Y, Sun L, Zhu Y BMC Genomics. 2022; 23(1):21.

PMID: 34983376 PMC: 8725419. DOI: 10.1186/s12864-021-08184-y.


Long Non-Coding RNA : Gene Structure, Expression, and Biological Relevance.

Szafranski P, Stankiewicz P Genes (Basel). 2021; 12(2).

PMID: 33513839 PMC: 7911649. DOI: 10.3390/genes12020177.


Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.

Huang Y, Wang X, Zheng Y, Chen W, Zheng Y, Li G Aging (Albany NY). 2021; 13(1):1153-1175.

PMID: 33428596 PMC: 7835059. DOI: 10.18632/aging.202254.


Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.

Zhao W, Wang J, Luo Q, Peng W, Li B, Wang L BMC Med Genomics. 2020; 13(1):185.

PMID: 33308216 PMC: 7731780. DOI: 10.1186/s12920-020-00834-6.


References
1.
Ringbaek T, BORGESKOV S, Lange P, Viskum K . Diagnostic and therapeutic process and prognosis in suspected lung cancer. Scand Cardiovasc J. 2000; 33(6):337-43. DOI: 10.1080/14017439950141399. View

2.
Haugen A, Ryberg D, Mollerup S, Zienolddiny S, Skaug V, Svendsrud D . Gene-environment interactions in human lung cancer. Toxicol Lett. 2000; 112-113:233-7. DOI: 10.1016/s0378-4274(99)00275-1. View

3.
Mattern J, Koomagi R, Volm M . Characteristics of long-term survivors of untreated lung cancer. Lung Cancer. 2002; 36(3):277-82. DOI: 10.1016/s0169-5002(02)00010-7. View

4.
Onganer P, Seckl M, Djamgoz M . Neuronal characteristics of small-cell lung cancer. Br J Cancer. 2005; 93(11):1197-201. PMC: 2361510. DOI: 10.1038/sj.bjc.6602857. View

5.
Zhang B, Horvath S . A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2006; 4:Article17. DOI: 10.2202/1544-6115.1128. View